Key result
Visceral obesity in patients with coronary artery disease was significantly associated with increased epicardial adipose tissue thickness (OR 1.9) and a pro-inflammatory adipokine-cytokine profile.
Why the study?
Does the presence of visceral obesity correlate with increased epicardial and perivascular fat thickness and altered adipokine-cytokine profiles in patients with coronary heart disease?
Cross-Sectional (n=84)
No
Does the presence of visceral obesity correlate with increased epicardial and perivascular fat thickness and altered adipokine-cytokine profiles in patients with coronary heart disease?
Visceral obesity in coronary heart disease patients is associated with increased epicardial and perivascular fat thickness and a more pro-inflammatory adipokine-cytokine profile.
Lower IL-10 in visceral obesity cautions against uniform cytokine assumptions in CAD; leaves open causal links to epicardial fat.
The aim of this study was to determine the relationship between the thickness of EAT and PVAT and the adipokine-cytokine profile of patients with coronary heart disease, which can be of significant importance for predicting the course of CVD. 84 patients with CVD, were assessed and divided into two groups based on the presence of visceral obesity (VO). In VO patients, the thickness of the epicardial deposits of the left and right ventricles were 1.75 and 1.43 times greater, respectively, than in patients without VO. For patients with VO, the prevalence of the volume of the left anterior descending artery was 10% higher, and the middle third of the envelope artery was 28% higher, when compared to patients without VO. When evaluating inflammatory status, it was established that the concentration of TNF-α and IL-1β, leptin in the blood serum of patients with VO exceeded the values of patients without VO. Level of proinflammatory IL-10 was 2-times lower in patients with VO. The findings of this study show that the increase of EAT and PVAT are independent risk factors of CVD, as well as a possible model for the assessment of drug effectiveness for CVD.
No takes yet. Share an insight, caveat, or question.
Груздева et al. (2018) conducted a cross-sectional in Coronary artery disease (n=84). Visceral obesity vs. Without visceral obesity was evaluated on Epicardial adipose tissue (EAT) thickness (OR 1.9, 95% CI 1.6-2.8). Visceral obesity in patients with coronary artery disease was significantly associated with increased epicardial adipose tissue thickness (OR 1.9) and a pro-inflammatory adipokine-cytokine profile.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: